Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Partner Fund Management and Pacira Pharmaceuticals Inc (PCRX)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Partner Fund Management 0 2,155,878 0 5.7%
Partner Fund Management GP 0 2,155,878 0 5.7%
Partner Investment Management 0 45,382 0 0.1%
Partner Investment Management GP 0 45,382 0 0.1%
Brian D. Grossman 0 2,201,260 0 5.9%
Christopher M. James 0 2,201,260 0 5.9%
Christopher Medlock James
Christopher Medlock James
Partner Fund Management

Page 1 of 13 – SEC Filing



Washington, D.C. 20549



(Rule 13d-102)


Information Statement Pursuant to Rules 13d-1
and 13d-2

Under the Securities Exchange Act of 1934

(Amendment No. __)*


Pacira Pharmaceuticals, Inc.

(Name of Issuer)

Common stock, par value $0.001 per share

(Title of Class of Securities)


(CUSIP Number)

April 4, 2017

Date of Event Which Requires Filing of the Statement

Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Follow Pacira Biosciences Inc. (NASDAQ:PCRX)
Trade (NASDAQ:PCRX) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
This is a FREE report from Insider Monkey. Credit Card is NOT required.